Retirement Systems of Alabama
NBIX icon

Retirement Systems of Alabama’s Neurocrine Biosciences NBIX Stock Holding History

Retirement Systems of Alabama’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.5M Sell
103,997
-19,043
-15% -$2.83M 0.05% 334
2026
Q1 		$16.2M Buy
123,040
+3,375
+3% +$448K 0.05% 350
2025
Q4 		$17M Sell
119,665
-252
-0.2% -$36.5K 0.06% 331
2025
Q3 		$16.8M Sell
119,917
-1,041
-0.9% -$141K 0.06% 337
2025
Q2 		$15.2M Sell
120,958
-394
-0.3% -$45.2K 0.05% 347
2025
Q1 		$13.4M Sell
121,352
-1,755
-1% -$222K 0.05% 374
2024
Q4 		$16.8M Buy
123,107
+446
+0.4% +$55.2K 0.06% 322
2024
Q3 		$14.1M Sell
122,661
-1,549
-1% -$212K 0.05% 378
2024
Q2 		$17.1M Sell
124,210
-745
-0.6% -$102K 0.07% 303
2024
Q1 		$17.2M Buy
124,955
+1,899
+2% +$259K 0.07% 315
2023
Q4 		$16.2M Buy
123,056
+1,128
+0.9% +$130K 0.07% 308
2023
Q3 		$13.7M Sell
121,928
-3,815
-3% -$402K 0.06% 320
2023
Q2 		$11.9M Sell
125,743
-460
-0.4% -$44.9K 0.05% 375
2023
Q1 		$12.8M Sell
126,203
-505
-0.4% -$52.5K 0.06% 368
2022
Q4 		$15.1M Buy
126,708
+1,500
+1% +$176K 0.07% 314
2022
Q3 		$13.3M Sell
125,208
-698
-0.6% -$70.8K 0.06% 316
2022
Q2 		$12.3M Buy
125,906
+1,429
+1% +$132K 0.05% 373
2022
Q1 		$11.7M Buy
124,477
+251
+0.2% +$21.3K 0.04% 442
2021
Q4 		$10.6M Buy
124,226
+1,677
+1% +$154K 0.04% 502
2021
Q3 		$11.8M Sell
122,549
-623
-0.5% -$58.8K 0.04% 433
2021
Q2 		$12M Buy
123,172
+3,360
+3% +$322K 0.04% 451
2021
Q1 		$11.7M Buy
+119,812
New +$12.6M 0.04% 454

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Retirement Systems of Alabama's NBIX Position: Q2 2026 in Review

Retirement Systems of Alabama reduced its Neurocrine Biosciences (NBIX) stake by 15% in Q2 2026, selling an estimated $2.83M and leaving 103,997 shares worth $17.5M. The position accounts for 0.05% of the portfolio, ranked #334.

Retirement Systems of Alabama first reported a position in NBIX in Q1 2021 and has held it in 22 quarters since. 779 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Retirement Systems of Alabama held 103,997 shares of Neurocrine Biosciences worth $17.5M as of Q2 2026.
  • Retirement Systems of Alabama sold 19,043 Neurocrine Biosciences shares in Q2 2026, an estimated $2.83M.
  • Neurocrine Biosciences made up 0.05% of Retirement Systems of Alabama's portfolio in Q2 2026, its #334 holding.
  • Retirement Systems of Alabama first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 22 quarters since.
  • 779 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Retirement Systems of Alabama's 13F filing for Q2 2026, filed 28 Jul 2026.